RCEL Insider Trading Activity and SEC Form 4 Filings
RCEL insider trading summary
Over the past 12 months, insiders at AVITA Medical, Inc. (RCEL) reported 11 open-market purchases worth $185K by 2 insiders and no sales on SEC Form 4. Net insider buying was $185K.
Latest RCEL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 12, 2026 | David D O'Toole | CFO | Buy | $8K (2,000 @ $3.97) |
| Jun 9, 2026 | Joseph Fralin Woody | Insider | Buy | $21K (5,000 @ $4.18) |
| Jun 9, 2026 | Joseph Fralin Woody | Insider | Buy | $21K (5,000 @ $4.20) |
| Jun 9, 2026 | Joseph Fralin Woody | Insider | Buy | $21K (5,200 @ $4.00) |
| Jun 2, 2026 | Joseph Fralin Woody | Insider | Buy | $21K (5,000 @ $4.21) |
| Jun 2, 2026 | Joseph Fralin Woody | Insider | Buy | $21K (5,000 @ $4.18) |
| Jun 1, 2026 | Joseph Fralin Woody | Insider | Buy | $21K (5,000 @ $4.26) |
| Jun 1, 2026 | Joseph Fralin Woody | Insider | Buy | $22K (5,000 @ $4.34) |
| May 20, 2026 | David D O'Toole | CFO | Buy | $9K (2,000 @ $4.26) |
| May 19, 2026 | David D O'Toole | CFO | Buy | $8K (2,000 @ $4.24) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.